Cormorant Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-50,000
| Closed | -$1.41M | – | 80 |
|
|
2019
Q3 | $1.41M | Sell |
50,000
-25,000
| -33% | -$703K | 0.09% | 60 |
|
|
2019
Q2 | $2.84M | Sell |
75,000
-25,000
| -25% | -$947K | 0.16% | 59 |
|
|
2019
Q1 | $3.9M | Sell |
100,000
-21,797
| -18% | -$851K | 0.26% | 52 |
|
|
2018
Q4 | $2.6M | Sell |
121,797
-3,203
| -3% | -$68.3K | 0.21% | 57 |
|
|
2018
Q3 | $4.95M | Sell |
125,000
-197,945
| -61% | -$7.84M | 0.32% | 46 |
|
|
2018
Q2 | $12.3M | Hold |
322,945
| – | – | 0.91% | 31 |
|
|
2018
Q1 | $9.7M | Sell |
322,945
-14,931
| -4% | -$449K | 0.72% | 25 |
|
|
2017
Q4 | $10.6M | Buy |
337,876
+14,331
| +4% | +$448K | 1.11% | 23 |
|
|
2017
Q3 | $9.06M | Hold |
323,545
| – | – | 1.6% | 21 |
|
|
2017
Q2 | $6.19M | Sell |
323,545
-101,115
| -24% | -$1.93M | 1.03% | 27 |
|
|
2017
Q1 | $7.24M | Sell |
424,660
-25,000
| -6% | -$426K | 1.05% | 32 |
|
|
2016
Q4 | $8.22M | Hold |
449,660
| – | – | 1.11% | 28 |
|
|
2016
Q3 | $8.01M | Buy |
+449,660
| New | +$8.01M | 0.88% | 37 |
|